Log In
Print
BCIQ
Print
Print this Print this
 

RP5063

  Manage Alerts
Collapse Summary General Information
Company Reviva Pharmaceuticals Inc.
DescriptionPartial agonist of the dopamine D2, D3 and D4 receptors and the serotonin 5-HT1A and 5-HT2A receptors, and antagonist of the serotonin 5-HT6 and 5-HT7 receptors
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT1A) receptor
Mechanism of ActionDopamine receptor agonist; Serotonin (5-HT1A) receptor agonist; Serotonin (5-HT6) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia and schizoaffective disorder
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today